Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
Nichola Cooper, Waleed Ghanima, Quentin A. Hill, et al.
Platelets (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Fostamatinib alleviates temporomandibular joint osteoarthritis by maintaining cartilage homeostasis through MAPK/NF-κB and AKT/mTOR pathways
Yuxin Zhang, Dahe Zhang, Qingyu Xu, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113996-113996
Closed Access | Times Cited: 1
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
David J. Kuter, Caroline I. Piatek, Alexander Röth, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 79-87
Open Access | Times Cited: 15
Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications
Zhen-Xi Niu, Jing Hu, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116446-116446
Closed Access | Times Cited: 6
A novel natural Syk inhibitor suppresses IgE-mediated mast cell activation and passive cutaneous anaphylaxis
Lele Wang, Yuzhen Fang, Yuqing Ma, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107320-107320
Open Access | Times Cited: 5
AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence
Shixiong Peng, Wenjie Yan, Yan Yang, et al.
International Journal of Biological Macromolecules (2025), pp. 139757-139757
Closed Access
Spleen tyrosine kinase aggravates intestinal inflammation through regulating inflammatory responses of macrophage in ulcerative colitis
Leilei Chen, Fengqin Zhu, Xizhuang Gao, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114122-114122
Open Access
Advances in Synthetic Immunology for Targeted Treatment of Systemic Autoimmune Diseases: Opportunities, Challenges, and Future Directions
Galih Januar Adytia, Henry Sutanto, Laras Pratiwi, et al.
Immuno (2025) Vol. 5, Iss. 1, pp. 6-6
Open Access
Morus alba L. alleviates influenza viral pneumonia. Evidences of its mechanism of action
Junsong Jing, Yi Sun, Yanna Shui, et al.
Phytomedicine (2025) Vol. 140, pp. 156574-156574
Closed Access
ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats
Dana N. LeVine, Robert Goggs, Barbara Kohn, et al.
Journal of Veterinary Internal Medicine (2024) Vol. 38, Iss. 4, pp. 1982-2007
Open Access | Times Cited: 4
B cells and antibodies in refractory immune thrombocytopenia
A. Roeser, Alan H. Lazarus, Matthieu Mahévas
British Journal of Haematology (2023) Vol. 203, Iss. 1, pp. 43-53
Open Access | Times Cited: 11
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM
Frances M. Bashore, V.L. Katis, Yuhong Du, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0293548-e0293548
Open Access | Times Cited: 3
The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review
Mohammad Ali Nilforoushzadeh, Nazila Heidari, Amirhossein Heidari, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111827-111827
Closed Access | Times Cited: 2
New insights into SYK targeting in solid tumors
Shweta Joshi
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 2
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View
Tomás José González‐López, Adrian C. Newland, Drew Provan
Medicina (2023) Vol. 59, Iss. 4, pp. 815-815
Open Access | Times Cited: 7
Blockade of Syk modulates neutrophil immune-responses via the mTOR/RUBCNL-dependent autophagy pathway to alleviate intestinal inflammation in ulcerative colitis
Fengqin Zhu, Dehuai Jing, Huihui Zhou, et al.
Precision Clinical Medicine (2023) Vol. 6, Iss. 4
Open Access | Times Cited: 7
Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors
Mohd Danishuddin, Md. Zubbair Malik, Mohammad Kashif, et al.
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 4, pp. 325-342
Closed Access | Times Cited: 1
A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer
Fang Jin, Ying Wang, Chen Li, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2565-2579
Open Access | Times Cited: 1
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, et al.
Annals of Hematology (2024)
Open Access | Times Cited: 1
Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective
Daniel Martínez‐Carballeira, Ángel Bernardo, Alberto Caro, et al.
Hematology Reports (2024) Vol. 16, Iss. 3, pp. 390-412
Open Access | Times Cited: 1
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies
Shreyash Dalmia, Brian Harnett, Hanny Al‐Samkari, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 9, pp. 609-616
Closed Access | Times Cited: 1
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction
Yuhong Du, Dongxue Wang, V.L. Katis, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100177-100177
Open Access | Times Cited: 1
Chromosome‐level genome assembly of Iodes seguinii and its metabonomic implications for rheumatoid arthritis treatment
Xun Gong, Hantao Zhang, Yong Guo, et al.
The Plant Genome (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes
Qian Jia, Qincheng Che, Xiaoyu Zhang, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115994-115994
Open Access | Times Cited: 4
Neuroblastoma—A Review of Combination Immunotherapy
Barbara Pieniążek, Katarzyna Cencelewicz, Patrycja Bździuch, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7730-7730
Open Access | Times Cited: 1
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top